Phase 1 clinical study of AS-0141 in advanced solid tumors
Latest Information Update: 18 Jun 2021
At a glance
- Drugs Monzosertib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man
- 18 Jun 2021 New trial record
- 22 Feb 2021 According to a Carna Biosciences media release, the Pharmaceuticals and Medical Devices Agency (PMDA) review for the clinical trial notification of AS-0141 to initiate this study has been successfully completed and the company expect to initiate this study in the first half of 2021.